GlaxoSmithKline invests $360 million in UK despite Brexit vote

LONDON (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signaling its confidence in the country despite last month's vote to leave the European Union.

Read More »